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Among Legionella species, which are recognized to be 
pathogenic for humans, L. gormanii is the second preva-
lent causative agent of community-acquired pneumonia 
after L. pneumophila. Anti-L. gormanii activity of Gal-
leria mellonella hemolymph extract and apolipophorin 
III (apoLp-III) was examined. The extract and apoLp-III 
at the concentration 0.025 mg/ml caused 75% and 10% 
decrease of the bacteria survival rate, respectively. The 
apoLp-III-induced changes of the bacteria cell surface 
were analyzed for the first time by atomic force micros-
copy. Our studies demonstrated the powerful anti-Legio-
nella effects of the insect defence polypeptides, which 
could be exploited in drugs design against these patho-
gens.
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INTRODUCTION
Currently, members of the family Legionellaceae com-
prise 58 described species that are highly successful in 
colonizing natural aquatic environments (Euzeby, 2013). 
A particular hallmark of these bacteria is their dual host 
system allowing intracellular growth in protozoa (from 
the genera Acanthamoeba, Naegleria, Hartmanella) and in 
human alveolar macrophages during infection (Fields 
et al., 2002). The ability to survive and replicate inside 
unicellular organisms contributed to the acquisition of 
virulence factors that enable Legionella to overcome the 
antimicrobial activities of human macrophages. The clini-
cal manifestations of Legionella infections are primarily re-
lated to the respiratory tract. The most common presen-
tation is acute pneumonia, which varies in severity from 
mild illness to fatal multilobar pneumonia. Legionella is 
widely recognised as an important source of communi-
ty- and hospital-acquired pneumonia. The second form 
of a respiratory illness is called Pontiac fever, which is a 
flu-like infection (Palusinska-Szysz & Cendrowska-Pinko-
sz, 2009). The first described Legionella species, L. pneu-
mophila, is unceasingly the dominating species among 
clinical isolates, whereas L. gormanii is the second preva-
lent causative agent of community-acquired pneumonia 
(Lode, 1987). Legionella infections are difficult to treat be-
cause of their intracellular localization in phagocytic cells. 
Moreover, bacteria released from A. castellanii are more 
resistant to chemical disinfectants and antibiotics used to 
treat pneumonia in comparison with those residing out-
side amoebae in the environment or laboratory cultured 
on Legionella  artificial medium. A combination of fluo-
roquinolones with macrolides is an effective method of 
Legionnaires’ disease treatment. However, the mortality 
rate among patients with hospital-acquired pneumonia 
is 14%, and with community-acquired pneumonia rang-
es from 5 to 10% (Benin et al., 2002; Palusinska-Szysz, 
2011). Therefore, the development of new antibacterial 
agents for Legionella infections is urgently needed.
A rich source of natural defence peptides (antimicro-
bial peptides; AMPs) with different biochemical proper-
ties and antimicrobial activity is insect’s hemolymph (Bu-
let et al., 2004; Bulet & Stöcklin, 2005). Due to amino 
acid composition, amphipathicity, cationic charge, and 
molecular size, AMPs can interact with microbial cell 
membranes forming toroidal or barrel-stave pores, or 
micelles composed of peptides and the membrane phos-
pholipid molecules. Disturbing a proper structure of a 
cell membrane leads to depolarization, increased per-
meabilization, and even membrane fragmentation, which 
results in death of the invading microbes (Bulet et al., 
2004). These properties and selective toxicity towards 
some pathogens make them the patterns for designing 
drugs alternative to antibiotics.
A great arsenal of defence peptides of different bio-
chemical and antimicrobial properties has been de-
scribed in Galleria mellonella immune hemolymph. In ad-
dition, lysozyme and apolipophorin III (apoLp-III) play 
important role in the insect immune response against 
bacteria and fungi (Hultmark, 1996; Weers & Ryan, 
2006; Cytryńska et al., 2007; Brown et al., 2008; 2009; 
Zdybicka-Barabas et al., 2013). ApoLp-III, an abun-
dant hemolymph protein, is involved in lipid transport 
and immune reactions. Because of lipopolysaccharide 
(LPS), lipoteichoic acid (LTA), and β-1,3-glucan binding 
ability, the protein is considered as an important pat-
tern recognition receptor (Halwani et al., 2000; Pratt & 
Weers, 2004; Whitten et al., 2004; Zdybicka-Barabas & 
Cytryńska, 2013). The defence proteins and peptides iso-
lated in our laboratory from immune hemolymph of G. 
mellonella larvae exhibit antimicrobial activity against dif-
ferent fungi, Gram-positive and Gram-negative bacteria 
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(Cytryńska et al. 2007; Zdybicka-Barabas & Cytryńska, 
2011; Zdybicka-Barabas et al., 2012a; 2012b; 2013). Re-
cently, the greater wax moth G. mellonella has been suc-
cessfully used to study pathogenesis and infection by dif-
ferent human pathogenic bacteria and fungi, including L. 
pneumophila (Harding et al., 2012; 2013a; 2013b). In our 
previous study, anti-L. dumoffii activity of G. mellonella 
defensin and apoLp-III has been documented indicating 
promising potential of the insect defence factors in fight-
ing Legionella spp. (Palusinska-Szysz et al., 2012). 
In order to test antimicrobial activity of G. mellonella 
defence compounds against other species of Legionella, 
the effects of hemolymph methanolic extracts and the 
purified apoLp-III on L. gormanii cells were investigated. 
In addition, the apoLp-III-induced changes of the bac-
teria cell surface topography and properties were imaged 
and analyzed by atomic force microscopy (AFM). Our 
study is an attempt at assessment of the potential of the 
new agents in elimination of L. gormanii.
MATERIALS AND METHODS
Microorganisms and growth conditions. L. gormanii 
strain NCTC 11401 (Health Protection Agency Culture 
Collections, Salisbury, UK) was cultured on buffered 
charcoal-N-(2-acetamido)-2-aminoethanesulfonic acid 
(ACES) yeast extract agar plates (BCYE; pH 6.9) (Ox-
oid, Basingstoke, UK) for 72 h at 37°C in a humidified 
incubator (5% CO2) (Feeley et al., 1979). Micrococcus lute-
us ATCC 10240 and Escherichia coli D31 (Boman et al., 
1974) were grown in 2.5% Luria-Bertani (LB) medium at 
28oC and 37oC, respectively.
Insects immunization and preparation of hemo-
lymph methanolic extracts. The larvae of G. mellonella 
(Lepidoptera: Pyralidae) were reared on honeybee nest 
debris (a natural diet) at 30oC in the dark. The immune 
challenge was performed by puncturing of the last instar 
larvae with a needle dipped into a pellet containing live 
E. coli D31 and M. luteus cells. The immune hemolymph 
was collected 24 h after the challenge. The methanolic 
extracts containing antimicrobial peptides and proteins 
below 30 kDa were prepared from the hemocyte-free 
hemolymph and deprived of lipids as described earlier 
(Cytryńska et al., 2007). The protein concentration was 
determined by a Bradford method (Bradford, 1976) us-
ing bovine serum albumin as a standard.
Purification of apolipophorin III. G. mellonella 
apoLp-III was purified from the immune hemolymph 
extract as described in our previous study (Zdybicka-
Barabas et al., 2013). Briefly, the freeze-dried hemolymph 
extract dissolved in 0.1% trifluoroacetic acid (TFA) was 
subjected to the HPLC chromatography using a Dis-
covery Bio Wide Pore C18 4.6 mm × 250 mm column 
(Sigma-Aldrich, USA) and two buffer sets, A: 0.1% TFA 
(v/v), B: 0.07% TFA, 80% acetonitrile (v/v). A linear 
gradient from 30 to 70% of buffer B over 35 min and 
1 ml/min flow rate was applied. The homogenous frac-
tion containing apoLp-III was freeze-dried, subjected 
to weighting, redissolved in sterile deionized water, and 
stored at –80oC until use. The homogeneity and identity 
of apoLp-III was confirmed by SDS-PAGE electropho-
resis (Schägger & von Jagow, 1987) and by N-terminal 
sequencing on an automatic protein sequencer (Procise 
491, Applied Biosystems).
Antimicrobial assays. The activity of immune hemo-
lymph extract and apoLp-III against L. gormanii was car-
ried out using a colony counting assay as described pre-
viously (Palusinska-Szysz et al., 2012). Briefly, 10 µl of 
a bacterial suspension (obtained by 2×10–4 dilution of 
a suspension with OD620 = 0.1) was incubated without 
(control) or with the extract (final protein concentrations 
0.025–0.8 mg/ml) or apoLp-III (final protein concentra-
tions 0.025–0.2 mg/ml) at 37°C for 1 h. Then, the incu-
bation mixtures were spread onto BCYE medium plates, 
incubated for 4 days at 37°C, and the number of the 
colony-forming units (CFU) was determined. The mini-
mal inhibitory concentration (MIC) was defined at the 
concentration which yielded 95% inhibition of bacterial 
growth. The data were calculated from three independ-
ent experiments, each performed in triplicate.
Atomic force microscopy imaging of L. gormanii. 
Forty μl of a water suspension (OD620=0.2) containing 
the L. gormanii cells grown on BCYE medium were in-
cubated without (control) and in the presence of purified 
G. mellonella apoLp-III (final concentration 0.2 mg/ml) at 
37oC for 1 h. After centrifugation (8 000 × g, 10 min., 
4oC) the bacteria were suspended in 5 μl of pyrogen-free 
water, applied on the surface of mica discs and allowed 
to dry overnight at room temperature.
L. gormanii cell surface imaging was carried out using 
NanoScope V AFM (Veeco, USA) in “PeakForce QNM” 
operation mode with a NSG 30 silicon tip (spring con-
stant of 20N/m; NT-MDT, Russia) (Analytical Labora-
tory, Faculty of Chemistry, UMCS, Lublin, Poland). The 
data were analyzed with Nanoscope Analysis ver. 1.40 
software (Veeco, USA). Two fields on each mica disc 
were imaged. The roughness values were measured over 
the entire bacterial cell surface on 3 µm×3 µm areas. 
The average surface root-mean-square (RMS) roughness 
was calculated from forty fields (265 nm×265 nm).
Statistics. Statistical analysis was performed using the 
Wilcoxon’s paired test. The data were presented as ± 
standard deviation (SD) from three independent exper-
iments.
RESULTS AND DISCUSSION
The antibacterial activity of G. mellonella immune 
hemolymph extract against L. gormanii was evaluated. 
The results showed dose-dependent killing of L. gormanii 
cells by the extract (Table 1). The incubation of L. gor-
manii in the presence of the extract at the concentration 
0.025 mg/ml for 1 h caused more than 75% decrease 
of the bacteria survival rate compared to the control, 
Table 1. The growth inhibition of L. gormanii by G. mellonella im-
mune hemolymph extract.
Concentration of hemo-
lymph extract (mg/ml) Survival rate (%)
0 100 (%)
0.025   23.8 (±1.5) (%)
0.05   15 (±0.6) (%)
0.1   11 (±0.6) (%)
0.2     7 (±0.6) (%) 
0.4     6 (±0.6) (%)
0.8     5 (±0.6) (%)
L. gormanii was incubated with the G. mellonella immune hemolymph 
extract at the concentrations of 0–0.8 mg/ml at 37°C for 1 h. The bac-
teria were then seeded on BCYE agar plates and the colonies were 
counted after four days incubation at 37°C in a 5% CO2 atmosphere. 
Data were expressed as means ± S.D. of three independent experi-
ments.
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i.e. non-treated bacteria. The MIC value defined as the 
concentration yielding at least 95% inhibition of bacterial 
growth for the extract was determined to be 0.8 mg/ml. 
However, the extract used at the concentration 0.4 mg/
ml reduced the bacteria survival rate to almost the same 
extent, i.e. by 94%. Recently, we have reported that an-
timicrobial proteins and peptides of the G. mellonella im-
mune hemolymph extract inhibited L. dumoffii growth. 
When the extract was used at the concentration 0.4 mg/
ml, ca. 50% decrease of L. dumoffii survival rate was ob-
served (Palusinska-Szysz et al., 2012).
A main protein component of G. mellonella hemo-
lymph extract is apoLp-III (Cytryńska et al., 2007). 
Hence, the effect of apoLp-III on L. gormanii survival 
rate was studied. A colony counting assay using apoLp-
III at the concentrations 0.025–0.2 mg/ml revealed that 
L. gormanii cells were sensitive to apoLp-III. The protein 
at the concentration 0.2 mg/ml caused ca. 50% decrease 
of the bacteria survival rate (Fig. 1). Interestingly, when 
apoLp-III was used at the concentration 0.025 mg/ml, 
the survival rate of L. gormanii decreased only by 10%, 
whereas the hemolymph extract at the same concen-
tration caused 75% reduction of bacterial survivability 
(Fig. 1). The results indicated that although L. gormanii 
was susceptible to apoLp-III action, other proteinaceous 
(e.g. defence proteins and peptides) and non-protein-
aceous compounds present in G. mellonella hemolymph 
extract were probably also involved in killing of the bac-
teria. Increasing of the hemolymph extract and apoLp-
III concentrations above 0.8 mg/ml and 0.2 mg/ml, re-
spectively, did not reduce further L. gormanii survival rate 
(data not shown). However, the explanation of this fact 
needs further investigations.
In our previous papers, usefulness of an atomic force 
microscopy for analysis of an influence of G. mellonel-
la defence factors on bacterial and fungal cell surface 
has been demonstrated (Zdybicka-Barabas et al., 2011; 
2012a; 2012b; 2013). In this study, AFM was used for 
examining of the G. mellonella apoLp-III effect on L. gor-
manii cell surface. AFM imaging revealed that the sur-
face of L. gormanii control cells was covered with small 
uniform granules (Figs. 2, 3). On the surface of some 
control cells few shallow depressions were also visible. 
Figure 1. The effect of G. mellonella apoLp-III on L. gormanii 
survival rate. 
The bacteria were incubated with the G. mellonella apoLp-III at 
the concentrations of 0–0.2 mg/ml at 37°C for 1 h. Cells were then 
plated on BCYE agar and the number of colonies was counted 
after four days incubation at 37°C in a 5% CO2 atmosphere. Ex-
perimental results were mean ± S.D. of three independent experi-
ments. The Wilcoxon’s paired test was used for comparisons with-
in groups. p values *p≤0.001 were considered.
Figure 2. The effect of G. mellonella apoLp-III on L. gormanii cell surface topography. 
The cells were incubated without (control) or in the presence of apoLp-III (0.2 mg/ml) at 37oC for 1 h and then imaged by AFM. The 
height and “peak force error” images are presented. The white and black arrowheads indicate granules and furrows, respectively, on the 
control cells surface. The white arrows mark bubble-like features appearing on apoLp-III-treated cells.
126           2014E. Chmiel and others
In addition, the cells with uneven surface covered with 
furrows, some of them 10–20 nm deep and even 200 
nm wide, were detected in the control samples. In con-
trast, the most of the apoLp-III-exposed cells were dec-
orated with numerous rounded bubble-like features of 
different size, 15–20 nm in height and 100–200 nm in 
diameter (Figs. 2, 3). The alterations of the L. gormanii 
cell surface caused by apoLp-III were also reflected by 
1.44-fold increase in cell surface roughness, the param-
eter used to describe the structural heterogeneity of the 
bacterial cell surface. The RMS roughness values for the 
control and apoLp-III-treated cells were calculated as 
2.935 nm (±1.016) and 4.2305 nm (±1.003; p=0.00103), 
respectively. One of the reasons of the increase of the 
surface roughness could be rupturing of bacterial cell 
following the apoLp-III binding to LPS and phospholip-
ids, which was reported by Pratt & Weers (2004).
Although both L. dumoffii and L. gormanii were sensi-
tive to G. mellonella apoLp-III, the 8-fold lower concen-
tration of apoLp-III was sufficient to exert the same 
bactericidal effect on L. gormanii in comparison to L. 
dumoffii (Palusinska-Szysz et al., 2012). The high sensi-
tivity of L. gormanii to apoLp-III in comparison with L. 
dumoffii indicates that different Legionella species could 
exhibit diverse susceptibility to the insect-derived antimi-
crobial factors, possibly reflecting differences in the cell 
surface properties.
Searching for antimicrobials effective against L. gor-
manii is especially important since this species was iso-
lated from peadiatric cases. Moreover, antimicrobial ther-
apy commonly used in empirical pneumonia treatment 
in young patients is not effective against Legionella spp. 
(Ephros et al., 1989; Greenberg et al., 2006).
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